File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: The potential role of brain-derived neurotrophic factor (BDNF) in angiogenesis

TitleThe potential role of brain-derived neurotrophic factor (BDNF) in angiogenesis
Authors
Issue Date2006
PublisherKluwer Academic Publishers
Citation
The 2nd European Conference on Tumor Angiogenesis and Antiangiogenic Therapy (ECTA), Munich, Germany, 14-16 September 2006. In Angiogenesis, 2006, v. 9 n. S1, p. 19 Abstract no. P14 How to Cite?
AbstractBackground and Aim: Hepatocellular carcinoma (HCC) is a hypervascularized solid tumor, where angiogenesis plays an essential role. The molecular mechanism of angiogenesis remains largely unclear. The present study aims to investigate the potential role of BDNF, one member of the neurotrophin family, in the angiogenic behavior of endothelial cells. Materials and methods: One normal mouse endothelial cell line (MILE SVEN 1) and one tumor-derived endothelial cell line (SVEC4-10EE2) were used in an in vitro setting. These two cell lines were treated with recombinant BDNF protein, TrkB blocker-K252a and BDNF combined with K252a. The viability of cells was determined by MTT assay, and VEGF were detected by semiquantitative a The expression of BDNF, HIF-1 RTPCR and Western blot. Results: The two cell lines expressed different levels of endogenous BDNF. The tumor-derived endothelial cells, which had a higher level of endogenous BDNF, demonstrated a higher proliferation rate than the normal endothelial cells, which had a lower endogenous BDNF level. Exogenous BDNF administration could promote cell proliferation in both cell lines. The tumor-derived endothelial cell line expressed BDNF receptor p75NTR, whereas the normal endothelial cell line expressed another BDNF receptor TrkB. BDNF and VEGF in the tumor-derived a upregulated the expression of BDNF, HIF-1 endothelial cells, but it could only augment the expression of BDNF and VEGF in the normal endothelial cells. Conclusion: BDNF might play an important role in mediating the angiogenic behavior of endothelial cells in both pathological and physiological conditions through different molecular pathways.
Persistent Identifierhttp://hdl.handle.net/10722/108614
ISSN
2015 Impact Factor: 4.301
2015 SCImago Journal Rankings: 2.212

 

DC FieldValueLanguage
dc.contributor.authorLam, CTen_HK
dc.contributor.authorYang, Zen_HK
dc.contributor.authorNgai, PPen_HK
dc.contributor.authorFan, STen_HK
dc.contributor.authorPoon, RTPen_HK
dc.date.accessioned2010-09-26T00:47:00Z-
dc.date.available2010-09-26T00:47:00Z-
dc.date.issued2006en_HK
dc.identifier.citationThe 2nd European Conference on Tumor Angiogenesis and Antiangiogenic Therapy (ECTA), Munich, Germany, 14-16 September 2006. In Angiogenesis, 2006, v. 9 n. S1, p. 19 Abstract no. P14-
dc.identifier.issn0969-6970-
dc.identifier.urihttp://hdl.handle.net/10722/108614-
dc.description.abstractBackground and Aim: Hepatocellular carcinoma (HCC) is a hypervascularized solid tumor, where angiogenesis plays an essential role. The molecular mechanism of angiogenesis remains largely unclear. The present study aims to investigate the potential role of BDNF, one member of the neurotrophin family, in the angiogenic behavior of endothelial cells. Materials and methods: One normal mouse endothelial cell line (MILE SVEN 1) and one tumor-derived endothelial cell line (SVEC4-10EE2) were used in an in vitro setting. These two cell lines were treated with recombinant BDNF protein, TrkB blocker-K252a and BDNF combined with K252a. The viability of cells was determined by MTT assay, and VEGF were detected by semiquantitative a The expression of BDNF, HIF-1 RTPCR and Western blot. Results: The two cell lines expressed different levels of endogenous BDNF. The tumor-derived endothelial cells, which had a higher level of endogenous BDNF, demonstrated a higher proliferation rate than the normal endothelial cells, which had a lower endogenous BDNF level. Exogenous BDNF administration could promote cell proliferation in both cell lines. The tumor-derived endothelial cell line expressed BDNF receptor p75NTR, whereas the normal endothelial cell line expressed another BDNF receptor TrkB. BDNF and VEGF in the tumor-derived a upregulated the expression of BDNF, HIF-1 endothelial cells, but it could only augment the expression of BDNF and VEGF in the normal endothelial cells. Conclusion: BDNF might play an important role in mediating the angiogenic behavior of endothelial cells in both pathological and physiological conditions through different molecular pathways.-
dc.languageengen_HK
dc.publisherKluwer Academic Publishers-
dc.relation.ispartofAngiogenesisen_HK
dc.titleThe potential role of brain-derived neurotrophic factor (BDNF) in angiogenesisen_HK
dc.typeConference_Paperen_HK
dc.identifier.emailLam, CT: sctlam@graduate.hku.hken_HK
dc.identifier.emailYang, Z: zfyang@hkucc.hku.hken_HK
dc.identifier.emailNgai, PP: ppngai@hotmail.comen_HK
dc.identifier.emailFan, ST: stfan@hku.hken_HK
dc.identifier.emailPoon, RTP: poontp@hkucc.hku.hken_HK
dc.identifier.authorityFan, ST=rp00355en_HK
dc.identifier.authorityPoon, RTP=rp00446en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s10456-006-9043-z-
dc.identifier.hkuros135825en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats